公司資料
ResMed 股價、新聞與催化劑
- 股票代碼:
- RMD
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
221.15 USD (+0.02%)
收盤價
最後更新: 2026年10月1日
26.5B USD
市值
股價為何變動
截至 2026年10月1日，RMD 股價變化不大，收於 $221.15。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.
所在地與產業分類
Headquartered in the United States and listed on NYSE, ResMed has a global healthcare footprint. It sits in medtech and digital health rather than therapeutic biotech.
商業模式特徵
The company generates revenue from PAP devices, masks, accessories, and connected-care services. Investors watch device adoption, sleep market demand, and the balance between recurring supplies and new product growth.
生技產業定位
ResMed is outside biotech but important in healthcare technology because of its recurring device model. It moves on procedure and chronic-care demand rather than on clinical-trial catalysts.
未來催化劑
- ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。